|
|
||||||||
1 Laboratory of Kidney and Electrolyte Metabolism and 2 Laboratory of Molecular Immunology, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892; 3 Department of Cell Biology, Georgetown University School of Medicine, Washington, District of Columbia 20007; and 4 Department of Cell Biology, Institute of Anatomy, University of Aarhus, DK-8000 Aarhus, Denmark
Cyclooxygenase inhibitors, such as indomethacin
and diclofenac, have well-described effects to enhance renal water
reabsorption and urinary concentrating ability.
Concentrating ability is regulated in part at the level of the thick
ascending limb of Henle's loop, where active NaCl absorption drives
the countercurrent multiplication mechanism. We used semiquantitative
immunoblotting to test the effects of indomethacin and diclofenac,
given over a 48-h period, on the expression levels of the ion
transporters responsible for active NaCl transport in the thick
ascending limb. Both agents strongly increased the expression level of
the apical Na-K-2Cl cotransporter in both outer medulla and cortex.
Neither agent significantly altered outer medullary expression levels
of other thick ascending limb proteins, namely, the type 3 Na/H
exchanger (NHE-3), Tamm-Horsfall protein, or
1- or
1-subunits of
the Na-K-ATPase. Administration of the EP3-selective PGE2
analog, misoprostol, to indomethacin-treated rats reversed the
stimulatory effect of indomethacin on Na-K-2Cl cotransporter
expression. We conclude that cyclooxygenase inhibitors enhance urinary
concentrating ability in part through effects to increase Na-K-2Cl
cotransporter expression in the thick ascending limb of Henle's loop.
This action is most likely due to elimination of an
EP3-receptor-mediated tonic inhibitory effect of
PGE2 on cAMP production.
urinary concentration mechanism; prostaglandins; indomethacin; diclofenac
This article has been cited by other articles:
![]() |
G.-H. Kim, N. W. Choi, J.-Y. Jung, J.-H. Song, C. H. Lee, C. M. Kang, and M. A. Knepper Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2 Am J Physiol Renal Physiol, April 1, 2008; 294(4): F702 - F709. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Norregaard, B. L. Jensen, S. O. Topcu, M. Diget, H. Schweer, M. A. Knepper, S. Nielsen, and J. Frokiaer COX-2 activity transiently contributes to increased water and NaCl excretion in the polyuric phase after release of ureteral obstruction Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1322 - F1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Mount Membrane trafficking and the regulation of NKCC2 Am J Physiol Renal Physiol, March 1, 2006; 290(3): F606 - F607. [Full Text] [PDF] |
||||
![]() |
R. Norregaard, B. L. Jensen, C. Li, W. Wang, M. A. Knepper, S. Nielsen, and J. Frokiaer COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction Am J Physiol Renal Physiol, August 1, 2005; 289(2): F322 - F333. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gamba Molecular Physiology and Pathophysiology of Electroneutral Cation-Chloride Cotransporters Physiol Rev, April 1, 2005; 85(2): 423 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Shankar and D. C. Brater Loop diuretics: from the Na-K-2Cl transporter to clinical use Am J Physiol Renal Physiol, January 1, 2003; 284(1): F11 - F21. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masilamani, X. Wang, G.-H. Kim, H. Brooks, J. Nielsen, S. Nielsen, K. Nakamura, J. B. Stokes, and M. A. Knepper Time course of renal Na-K-ATPase, NHE3, NKCC2, NCC, and ENaC abundance changes with dietary NaCl restriction Am J Physiol Renal Physiol, October 1, 2002; 283(4): F648 - F657. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jeck, S. C. Reinalter, T. Henne, W. Marg, R. Mallmann, K. Pasel, M. Vollmer, G. Klaus, A. Leonhardt, H. W. Seyberth, et al. Hypokalemic Salt-Losing Tubulopathy With Chronic Renal Failure and Sensorineural Deafness Pediatrics, July 1, 2001; 108(1): e5 - 5. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |